These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 12840201)

  • 1. Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats.
    Aziz A; Anderson GH
    J Nutr; 2003 Jul; 133(7):2326-30. PubMed ID: 12840201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4, a GLP-1 receptor agonist, modulates the effect of macronutrients on food intake by rats.
    Aziz A; Anderson GH
    J Nutr; 2002 May; 132(5):990-5. PubMed ID: 11983826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats.
    Peters CT; Choi YH; Brubaker PL; Anderson GH
    J Nutr; 2001 Aug; 131(8):2164-70. PubMed ID: 11481412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides.
    Aziz A; Anderson GH; Giacca A; Cho F
    Am J Physiol Regul Integr Comp Physiol; 2005 Sep; 289(3):R688-94. PubMed ID: 15879053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
    Bojanowska E; Radziszewska E
    J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
    Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
    Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
    Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
    Burmeister MA; Ayala J; Drucker DJ; Ayala JE
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
    Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
    Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats.
    McKay NJ; Daniels D
    J Neuroendocrinol; 2013 Oct; 25(10):929-38. PubMed ID: 23957745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
    Wang L; Guo F; Wei S; Zhao R
    Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.
    Li L; El-Kholy W; Rhodes CJ; Brubaker PL
    Diabetologia; 2005 Jul; 48(7):1339-49. PubMed ID: 15902400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
    Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
    Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals.
    Malendowicz LK; Nowak KW
    Int J Mol Med; 2002 Sep; 10(3):327-31. PubMed ID: 12165809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor.
    Washington MC; Raboin SJ; Thompson W; Larsen CJ; Sayegh AI
    Brain Res; 2010 Jul; 1344():124-33. PubMed ID: 20452329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
    Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
    Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exendin-4, a GLP-1 receptor agonist, stimulates pituitary-adrenocortical axis in the rat: Investigations into the mechanism(s) underlying Ex4 effect.
    Malendowicz LK; Nussdorfer GG; Nowak KW; Ziolkowska A; Tortorella C; Trejter M
    Int J Mol Med; 2003 Aug; 12(2):237-41. PubMed ID: 12851724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.